Answers are grounded in this paper and cite their sources.
Potassium (K + ) channels regulate cellular homeostasis and electrical signaling, particularly in the nervous system, and their dysfunction is linked to neurological disorders such as epilepsy, Alzheimer’s disease (AD), and Parkinson’s disease (PD). In this study, Gene Expression Omnibus (GEO) datasets (GSE252132, GSE190451, and GSE160299) were analyzed using GEO2R to identify differentially expressed K + channel genes. A total of 2741, 3681, and 861 differentially expressed genes were identified in AD, epilepsy, and PD, respectively, including the common K + channel genes KCNJ5 , KCNJ6 , and KCNJ12 . Functional enrichment using Enrichr highlighted potassium ion transport, potassium channel complexes, voltage-gated potassium channel activity, and gonadotropin-releasing hormone secretion. STRING and Cytoscape-based protein–protein interaction and Molecular Complex Detection analyses identified 13 hub genes, including KCNJ6 , KCNJ5 , and KCNJ12 . miRNet analysis identified 12 miRNAs, 1 transcription factor, and 7 target genes, with hsa-miR-138-5p predicted to regulate KCNJ6 . Virtual screening of 2315 Food and Drug Administration-approved drugs and 2390 Traditional Chinese Medicine compounds identified Sorafenib, Hinokiflavone, Posaconazole, and 1,3,6-Tri-O-galloyl-beta-D-glucose as promising KCNJ6 -binding candidates. These findings highlight K + channels, particularly KCNJ6 , as biomarkers and therapeutic targets in neurological disorders.
No takes yet. Share an insight, caveat, or question.
Maqsood et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: